11
Marino Nebuloni, Patrizia Colombo: Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride. TONIX PHARMA HOLDINGS, Ropes & Gray, May 2, 2017: US09636408

The present invention relates to pharmaceutical compositions and methods of manufacturing the same, comprising a eutectic of Cyclobenzaprine HCl and mannitol or Amitriptyline HCl and mannitol.


12
Jan Steyaert, Toon Laeremans, Els Pardon: Chimeric polypeptides comprising G protein-coupled receptors and VHH antibodies. VIB VZW, Vrije Universiteit Brussel, TraskBritt P C, March 14, 2017: US09593157

Described are polypeptides and their use for screening and drug discovery. More specifically, the disclosure provides chimeric polypeptides comprising a membrane protein, in particular a GPCR, fused to a binding domain, wherein the binding domain is directed against and/or specifically binds to the ...


13
Natasha Faith Cover, Anna K Parsons, Arun Kumar: Device for sterile uterine sampling and drug delivery. University of South Florida, Michele L Lawson, Smith & Hopen P A, August 15, 2017: US09730679

A device and method for the collection of sterile specimen samples from the uterus is presented. Also presented is a method of delivering nano-encapsulated drugs to the female reproductive tract to treat pelvic inflammatory disease. The device generally is comprised of an outer cannula over which a ...


14
Howard E Greene: Infusion delivery devices and methods. Acuity Law Group P C, Daniel M Chambers, May 23, 2017: US09656017

Devices that include multi-reservoir infusion devices and systems for dispensing compositions for the treatment of subjects with an amylin agonist (e.g., the amylin agonist analog, pramlintide), wherein amylin agonists are administered in certain differential bolus and basal ratios to an administere ...


15
Jan Spanholtz: Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics. IPD THERAPEUTICS, Hoffmann & Baron, August 18, 2015: US09109202

The invention provides means and methods for stem cell proliferation and subsequent generation and expansion of progenitor cells. The invention in particular provides media and other culture conditions for the same. The cells are preferably used as effector cells as clinical therapeutics.


16
Narendra Kumar, Jayshree Mishra: Methods of screening for Janus kinase 3 interacting compounds. Benjamin Aaron Adler, August 22, 2017: US09739779

The present invention provides a method for screening compounds for their ability to inhibit autophosphorylation of Janus kinase 3 in the absence of any additional substrate. The present invention also provides a method for screening compounds that bind to Janus kinase 3 domains other than the kinas ...


17
Wu Jingbo: Anti-tumor biologically active substance and preparation technology thereof. Affiliated Hospital Of Luzhou Medical College, weichang wei, April 30, 2008: CN200710050378

The invention discloses an antineoplastic biological active substance, which can culture heart tissue to antineoplastic cardiocytes culture fluid. The concrete steps are that cell suspension is made, alternate freezing and thawing is processed and centrifugal is filtered. The invention proves that t ...


18
Zhang Wei, Jin Guohua, Xu Xiaole: Compound fleece-flower root extract capsule and preparation method and usage thereof. Nantong University, Ge Lei, March 17, 2010: CN200910233002

The invention discloses a compound fleece-flower root extract capsule and a preparation method and usage thereof. The capsule is made from fleece-flower root, grassleaved sweetflag, indianmulberry, ganoderma lucidum, anemarrhena and leech. Studies of experimental pharmacology and clinical therapeuti ...


19

20
Jan Spanholtz: Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics. Hoffmann & Baron, January 15, 2009: US20090017539-A1

The invention provides means and methods for stem cell proliferation and subsequent generation and expansion of progenitor cells. The invention in particular provides media and other culture conditions for the same. The cells are preferably used as effector cells as clinical therapeutics.



Click the thumbnails below to visualize the patent trend.